Skye Bioscience SG&A Expense (Semi Annual) Analysis

Skye Bioscience, Inc. (SKYE)

0.7144 +0.02 (+2.35%) USD | NASDAQ | Apr 06, 16:00

0.7085 -0.01 (-0.83%) After-Hours: 20:00

View SG&A Expense (Semi Annual) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Merck & Co., Inc.	--
SIGA Technologies, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--